Alteryx (AYX) Price Target Increased to $72.00 by Analysts at Bank of America

Alteryx (NYSE:AYX) had its target price upped by Bank of America from $54.00 to $72.00 in a report issued on Friday morning, Marketbeat reports. Bank of America currently has a buy rating on the stock.

Several other research firms also recently commented on AYX. Cowen lifted their price target on shares of Alteryx from $64.00 to $76.00 and gave the stock an outperform rating in a research note on Thursday. JMP Securities lifted their price target on shares of Alteryx from $52.00 to $64.00 and gave the stock an outperform rating in a research note on Thursday. Zacks Investment Research raised shares of Alteryx from a sell rating to a hold rating in a research note on Monday, September 24th. DA Davidson set a $66.00 price target on shares of Alteryx and gave the stock a hold rating in a research note on Thursday. They noted that the move was a valuation call. Finally, Needham & Company LLC lifted their price target on shares of Alteryx to $65.00 and gave the stock a buy rating in a research note on Monday, September 24th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of Buy and an average target price of $66.45.

Shares of AYX stock traded down $0.41 during trading hours on Friday, hitting $57.88. 936,512 shares of the company’s stock were exchanged, compared to its average volume of 1,147,495. The company has a market capitalization of $3.57 billion, a PE ratio of -186.71 and a beta of 0.99. Alteryx has a 12-month low of $23.00 and a 12-month high of $67.40. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.71 and a current ratio of 2.71.

Alteryx (NYSE:AYX) last posted its quarterly earnings results on Wednesday, November 7th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.10) by $0.13. The firm had revenue of $54.18 million for the quarter, compared to the consensus estimate of $49.79 million. Alteryx had a negative net margin of 6.72% and a negative return on equity of 7.38%. The business’s revenue was up 58.6% compared to the same quarter last year. During the same period last year, the firm posted $0.02 earnings per share. On average, research analysts predict that Alteryx will post -0.47 EPS for the current year.

In other news, major shareholder Abdiel Capital Management, Llc bought 29,855 shares of the firm’s stock in a transaction that occurred on Tuesday, October 23rd. The shares were bought at an average cost of $42.53 per share, with a total value of $1,269,733.15. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Insight Venture Partners Viii, sold 595,500 shares of Alteryx stock in a transaction on Monday, August 13th. The stock was sold at an average price of $55.62, for a total transaction of $33,121,710.00. Following the completion of the transaction, the insider now directly owns 930,005 shares in the company, valued at $51,726,878.10. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 194,855 shares of company stock worth $9,551,233 and sold 3,390,485 shares worth $187,381,390. 39.01% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in the stock. American International Group Inc. boosted its holdings in Alteryx by 6.4% in the third quarter. American International Group Inc. now owns 19,406 shares of the company’s stock valued at $1,110,000 after acquiring an additional 1,172 shares in the last quarter. Metropolitan Life Insurance Co. NY boosted its holdings in Alteryx by 20.9% in the second quarter. Metropolitan Life Insurance Co. NY now owns 9,182 shares of the company’s stock valued at $350,000 after acquiring an additional 1,585 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in Alteryx by 16.4% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 12,710 shares of the company’s stock valued at $727,000 after acquiring an additional 1,788 shares in the last quarter. MetLife Investment Advisors LLC boosted its holdings in Alteryx by 17.6% in the second quarter. MetLife Investment Advisors LLC now owns 12,993 shares of the company’s stock valued at $496,000 after acquiring an additional 1,948 shares in the last quarter. Finally, Bessemer Group Inc. bought a new stake in Alteryx in the third quarter valued at $140,000. Institutional investors and hedge funds own 43.05% of the company’s stock.

About Alteryx

Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts. Its software platform includes Alteryx Designer for data preparation, blending, and analytics that could be deployable in the cloud and on premise; Alteryx Server, a secure and scalable server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models to production; and Alteryx Analytics Gallery, a cloud-based collaboration offering that allows users to share workflows in a centralized repository.

Recommended Story: How to Invest in an Index Fund

Analyst Recommendations for Alteryx (NYSE:AYX)

Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply